Lipopolysaccharide induces recurrence of arthritis in rat joints previously injured by peptidoglycan-polysaccharide by unknown
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LPS and peptidoglycan or covalent peptidoglycan-polysaccharide (PG-PS)'
complexes are the major toxic components of bacterial cell walls . Lipid A and
PG possess many of the biologic activities that LPS and PG-PS, respectively, have
in common, such as pyrogenicity, polyclonal activation of lymphoid cells, com-
plement activation, mitogenicity, macrophage activation, and adjuvanticity (1-
3) . Both also induce arthritis after injection into laboratory animals . Systemic
injection of rats with a sterile, aqueous suspension of PG-PS from the group A
streptococcus (PG-APS) induces a chronic erosive relapsing arthritis that has
many features of rheumatoid arthritis (4-6) . Distinct PG-PS structures from a
number of other bacteria, including human indigenous intestinal species, induce
arthritis of varying chronicity (7-10) . LPS induces primarilyan acute arthritis of
relatively short duration after intraarticular (i.a .) injection (7, 11-15), but there
have been few reports of its arthropathic activity after systemic administration
(16, 17, 17a) .
In spite of the shared biologic properties and ubiquitous distribution of LPS
and PG-PS, the interaction oftheir phlogistic activities inan inflammatory process
has received little attention . During investigations of mechanisms of recurrent
arthritis induced by PG-APS, we noted that a systemic injection of 100 Ag of
Salmonella typhimurium LPS induced a transient recurrence of arthritis in rat
joints previously inflamed by exposure to PG-APS (7,18) . We now report that
the systemic injection ofa much lower dose of LPS will induce a recurrence of
arthritis injoints inflamed 3 wk previously by the intraarticular injection ofPG-
APS and describe this reaction in detail . We show that LPS from many bacteria,
including Yersinia enterocolitica and Neisseria gonorrhoeae, are active ; that lipid A
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' Abbreviations used in this paper.
￿
APS, groupA streptococcus polysaccharide ; i.a ., intraarticular;
PC, peptidoglycan; PS, polysaccharide .
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is the active moiety ; and that the reaction is influenced by the geneticbackground
of the rat . We provide evidence that the reaction is dependent upon the
persistence of high-molecular-weight PG-APS in the joint, and that T lympho-
cytes are not required . In addition, we show that, in -50% of naive, previously
uninjected rats, a high systemic dose of LPS induces a mild, transient acute
synovitis . These studies support the concepts that LPS and peptidoglycan can
interact in an inflammatory process and that LPS may play a role in recurrent
episodes ofrheumatoid arthritis or in reactive arthritis .
Materials and Methods
Source ofLPS, PG-APS, and Other Reagents .
￿
S . typhimurium wild type strain LT-2 LPS,
Escherichia coli strain 0111 :B4 LPS, and S . typhimurium Re mutant strain G30/C21 LPS
were purchased from Ribi Immunochem Research, Inc., Hamilton, MT . S. typhimurium
W LPS was purchased from Difco Laboratories, Detroit, MI . N. gonorrhoeae strain FA
5100 LPS (19) was a gift from W . M . Shafer, Emory University, Atlanta, GA . Y .
enterocolitica strainWA LPS was a gift from R . R . Brubaker, Michigan State University,
East Lansing, MI . S. minnesota Re mutant strain R595 LPS and E . coli Re mutant strain
515 lipid A were gifts from H . Brade, Forschungsinstitut, Borstel, Federal Republic of
Germany .
PG-APS was prepared by the SDS extraction of cell walls from Streptococcus pyogenes,
group A, strain D-58, as described in detail previously (10) . All of the experiments
reported here were done with a fraction of sonicated PGAPS fragments that sediment at
100,000 g but not at 10,000 g (the 100P fraction) . Fragments in this fraction have an
average mol wt of 5 x 10' (20) .
Polymyxin B sulfate (8,156 U/mg) was purchased from Sigma Chemical Co ., St. Louis,
MO .
Mutanolysin (N-acetylmuramidase) was purchased from Miles Laboratories, Inc ., Elk-
hart, IN . It was dissolved in PBS, pH 7, with briefsonication before injection into rats, as
described previously (21) .
Sterility of preparations for injection into rats was monitored by streaking on blood
agar plates .
Experimental Animals and Induction of Arthritis.
￿
Unless otherwise noted, experiments
were done with female rats, age 6-8 wk, purchased from the following sources : outbred
Sprague-Dawley rats from Zivic-Miller Laboratories, Allison Park, PA ; inbred Lewis rats
from Charles River Breeding Laboratories, Wilmington, PA ; and inbred Buffalo rats
from Simonsen Laboratories, Bilroy, CA .
Athymic Lewis rats (LEW rnu/rnu) and their euthymic (rnu/+) (22, 23) littermates
were produced by the School of Veterinary Medicine, North Carolina State University,
Raleigh, NC . The rats were obtained by backcrossing Rowett outbred nude rats onto
LEW/N females for over five generations . The animals were housed in filter-top cages
and fed autoclaved fortified rat chow and water .
LPS was dissolved in distilled H2O, with gentle sonication if necessary, and diluted to
the desired concentration in PBS . PG-APS was also suspended in PBS . Before injection,
LPS and PG-APS preparations were gently sonicated for 3 min in a 9 KHz Sonic Oscillator
(Raytheon Co ., Waltham, MA) to promote even dispersion . Rats were injected under
ether anesthesia . Intravenous injections (0.5 ml) were given in the tail vein . Intraarticular
injections (10 ul) were given in the anklejoint, through the Achilles tendon just proximal
to the calcaneous, using a 25-gauge needle adapted to a micropipette (7, 15). Injection
dosages and times are indicated in the Results . Typically, PG-APS (5 ug) or LPS (10 ug)1690
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TABLE I
Arthritis Induced by Systemic Injection of LPS into Naive (Previously Uninjected) Rats
Rat
￿
Dose
Arthritis 48 h after LIPS
injection
LIPS was injected intravenously into Sprague-Dawley rats. Control rats injected with PBS never developed arthritis.
* Number of rats that died/number of rats injected . All deaths occurred within 24 hof LIPS injection.
$ Number of rats having ajoint score of at least one/number of surviving rats .
Includes rats that did not developarthritis.
was injected in right ankles, and PBS (10 jAl) was injected in left ankles. 3 wk later, rats
received an intravenous injection of LPS or PG-APS. In some experiments, LPS was
injected intravenously into naive, previously uninjected rats.
The severity of arthritis was scored grossly on a scale of 0 (no apparent inflammation)
to 4 (severe inflammation) based on erythema and edema of the periarticular tissues and
enlargement of thejoints (4, 10). In several experiments, as indicated in the Results, the
presence of synovitis was confirmed by histologic study ofjoint sections. Rats were killed
with C02 and ankle joints were removed, skinned, fixed in formalin, decalcified, em-
bedded in paraffin, sectioned, and stained with H and E (4).
FACS Analysis ofSplenocytesfrom rnu/rnu and rnu/+ Rats.
￿
All mAbs were purchased
from Seralab (distributed by Accurate Chemical and Scientific Corp., Westbury, NY)
except MRC OX-1 and MRC OX-42, which were prepared as culture supernatants at the
North Carolina State University FACS/Hybridoma Facility, School of Veterinary Medi-
cine, North Carolina State University, Raleigh, NC using clones obtained from A. F.
Williams, Oxford (OX-1) and S. Brostoff, Charleston, SC (OX-42). The mouse anti-rat
leukocyte mAbs recognize the following determinants: MRC OX-1, a monomorphic
leukocyte common antigen (24); MRC OX-19, all thymocytes and peripheral T cells, and
a subset of B cells (25); MRC OX-8, most thymocytes, the cytotoxic/suppressor T cell
subset, and the majority of natural killer cells (26, 27); W3/25, most thymocytes, the
helper T cell subset, and macrophages (26, 28, 29, 30); MRC OX-7, a monomorphic Thy-
FIGURE 1.
￿
Histologic appearance of ankle joints following systemic injection of LPS. (A)
Acute synovitis, with an exudate containing polymorphonuclear leukocytes (PMNs) and fibrin
in the joint space, 48 h after intravenous injection of 50 ug of S. typhimurium LT-2 LPS in a
naive, previously uninjected Sprague-Dawley rat (X 120). All other sections (B-F) are from
Lewis rats 3 d after injection with various LPS preparations. 3 wk before LPS injection, the
right anklejoints of these rats had been injected intraarticularly with 5 pg of PG-APS, and the
left joints had been injected with PBS. (B) PG-APS-injected joint after intravenous injection
with 25 jig of N. gonorrhoeae LPS, showing a severe acute exudative inflammatory reaction.
Note the PMNs and fibrin in thejoint space (X 120). (C) PBS-injected joint of the rat described
in (B). The joint space is clear, and no inflammation is seen (X120). (D) PG-APS-injectedjoint
after intravenous injection with 25 tug of Y. enterocolitica LPS, showing PMNs and some
mononuclear cells in thejoint space and the synovial stroma. Hyperplasia ofthe synovial lining
cells is also seen. (X540). (E) PG-APS-injected joint after intravenous injection with 25 ug of
S. typhimurium Re mutant LPS, showing an acute exudative synovitis similar to that seen in (B)
and (D) above (x120). (F) PG-APS-injected joint after intravenous injection of a mixture of
25 1<g of S. typhimurium Re mutant LPS and 250 t<g of polymyxin B. No acute inflammation
is seen (X 120).
Exp. LPS
Average
age
wk
Average
weight
g
Micro-
grams per
rat
Micro-
gramsper
gram body
wt
Mortality*
Incidence$
Mean joint
score
(t SEM)f
1 S. typhimurium LT-2 LPS 6 130 50 0.39 6/11 2/5 1.0 :t 0.5
1 9 222 50 0.23 2/9 3/7 0.9 t0.4
1 16 364 50 0.14 0/9 3/9 1.3 t 0.4
1 28 412 50 0.12 0/9 5/9 1.4 t 0.4
2 S. typhimurium G30/C21 Re 8 150 100 0.67 0/7 5/7 1.5 t 0.3
mutant LIPS
2 S. minnesota R595 Re mu- 8 150 100 0.67 0/7 0/7 0
tant LIPSSTIMPSON ET AL .
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1 determinant on thymocytes and immature lymphocytes (31, 32) ; MRC OX-12, K light
chains (33) ; MRC OX-6, a monomorphic la determinant (34) ; and MRC OX-42, a
complement receptor type 3 determinant on macrophages, granulocytes, and dendritic
cells (35) . Splenocytes were analyzed on a FACS 440 (Becton Dickinson, Mountain View,
CA), essentially as described by White, et al . (30). Briefly, splenocyte suspensions were
prepared in RPMI-1640 containing 10 mM HEPES with no FCS or antibiotics (RPMI) .
mAb was added to aliquots of cellsand incubated at 4°C for 30 min . After washing, cells
were resuspended in FITC-conjugated goat anti-mouse IgG (FITC-anti-mouse IgG)
(Cappel Laboratories, West Chester, PA) and incubated at 4 0C for 30 min . The FITC-
anti-mouse IgG was diluted in 10% rat serum even though it was said to have no
crossreactivity with rat antigens . Finally, splenocytes were washed, resuspended in RPMI,
and analyzed . Controls included splenocyte suspensions incubated without mAb or with
FITC-anti-mouse IgG alone . Results are expressed as the mean percent of splenocytes
that are recognized by a given mAb, after subtracting the background binding by FITC-
anti-mouse IgG alone . This background was usually<6% andnot >8.8% .
Results
Acute Synovitis after Systemic Injection of Endotoxin in Naive Rats .
￿
A single
intravenous injection of S ., typhimurium LT-2 LPS into rats induced a transient
acute synovitis (Table I). By gross inspection, this reaction was most severe 24-
48 h after injection, then quickly resolved, and was usually undetectable by day
7. Re mutant LPS from S. typhimurium, but not from S. minnesota, was also able
to induce this reaction . Histologic studies revealed an acute exudative reaction,
with polymorphonuclear leukocytes and small amounts of fibrin in the joint
space, which was clearly evident 2d after injection (Fig . 1A) . Hyperplasia of the
synovial lining cells was also noted in many rats . By day 5, these reactions had
subsided, and by day 14 were gone, with little or no evidence of chronic
inflammation . The effect of rat age on the response to a single 50,ug i.v . dose of
LPS is shown in Table I. This was a lethal dose for many of the younger rats
and it induced transient diarrhea and a sickly appearance in most rats of all ages .
The severityandincidence ofarthritis didnot change significantlywith increased
age, even though the dose of LPS per gram of body weight decreased . This
indicated that older rats were at least as, and perhaps more susceptible to LPS-
induced synovitis than younger rats .
It should be emphasized that although the presence of this reaction could
easily be confirmed histologically, it was not very severe, was seen in only ^-50%
of rats injected with high doses ofLPS, and was easily overlooked in the gross if
rats were not examined carefully . Gross evidence of synovitis was noted only in
the anklejoints ; otherjoints were not examined histologically.
Recurrence ofArthritis after Systemic LPS Injection in joints Previously Exposed to
PG-APS . Intraarticular injection ofPG-APS into the rat anklejoint induced an
acute course of arthritis that peaked in severity 12-24 h after injection and
gradually subsided over the next 3 wk. Aside from a transient increase in joint
swelling in some rats 7-10 d after injection, arthritis resolved without sponta-
neous recurrence of inflammation .
Intravenous injection ofLPSinduceda recurrence ofarthritis injoints injected
3 wk previously with PG-APS . The severity of inflammation increased to a peak
48 h after LPS injection, and then gradually resolved over the next week . No
ankylosis or lasting loss of joint function was seen . The smallest dose of S .STIMPSON ET AL.
￿
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TABLE II
Recurrence ofArthritisInduced by Systemic Injection of Various Types and Doses ofLPS
Arthritis 48 h after LPS injection
PG-APS-injected
(riht ankle) PBS-injected (left) ankle
On day 0, therightankle ofeach rat received an intraarticular injection of 5,ug ofS. pyogenes PG-
APS. The left ankle received an intraarticular injection of PBS. 3 wk later, each rat received an
intravenous injection of LPS.
* Number of ankles in whichjoint score increased by at least one after intravenous LPS injection/
total number of ankles injected.
$Significance of the difference between the mean joint score of PG-APS-injected vs. PBS-injected
joints (t test forpaired samples).
Immediately before injection of LPS, the mean score of PG-APS-injected joints was never >0.4 ±
0.2, and PBS-injected joints showed no apparent inflammation. Mean joint scores for PG-APS-
injected ankles 48 h after LPS injection were significantly higher than those immediately before
LPS injection, except for the 1, 0.3, and 0.1 pg doses(p < 0.005, t test for paired samples).
Arthritis 72 h after LPS injection,
typhimurium LT-2 LPS that induced a recurrence of arthritis in 100% of PG-
APS-injectedjoints was 10 lAg, and a recurrence was induced with as little as 300
ng (Table II). LPS preparations from E. coli, Y. enterocolitica, and N. gonorrhoeae
were also active (Table II).
Representative clinical courses ofarthritis in Lewis and Buffalo rats are shown
in Fig. 2B . Arthritis induced by intraarticular injection ofPG-APS was less severe
in Buffalo than in Lewis rats. In addition, the recurrence ofarthritis induced by
the intravenous injection ofLPS in Buffalo rats was of lower incidence, severity,
and duration than in Lewis rats (Fig. 2B).
Histological studies were done to confirm and extend the clinical observations.
Immediately before intravenous injection ofLPS,joints injected 21 d previously
Exp. LPS Dose
Incidence*
Mean joint
score
(t SEM)
Incidence
Meanjoint
score
(t SEM)
Pt
Jug
1 S. typhimurium 100 7/7 2.2 t 0.34 5/7 1.1 ± 0.3 <0.001
LT-2
1 50 6/6 2.5 ± 0.3 4/6 1.1 t 0.2 <0.025
2 50 8/8 2.9 ± 0.1 6/8 1.2 ± 0.3 <0.001
1 25 8/8 2.3 t 0.2 4/8 0.6 t 0.3 <0.001
1 10 9/9 2.1 t 0.2 2/9 0.5 t 0.2 <0.001
2 10 8/8 2.4 ± 0.1 3/8 0.4 t 0.3 <0.001
3 10 7/8 2.0 t 0.4 2/8 0.2 t 0.1 <0.001
2 3 5/8 1.3 ± 0.3 0/8 0.1 t 0.1 <0.005
2 1 2/8 0.8 t 0.3 0/8 0
2 0.3 1/8 0.5 ± 0.2 0/8 0
2 0.1 0/8 0.5 ± 0.2 0/8 0
4 S. typhimurium 50 6/61 2.0 ± 0.3 0/6 0 <0.001
W
5 E. coli 100 8/8 2.3 ± 0.2 2/8 0.6 t 0.2 <0.001
6 Y. enterocoli- 25 8/8 2.5 t 0.3 2/8 0.5 ± 0.4 <0.001
tica
6 N. gonorrhoeae 25 8/8 2.6 t 0.2 0/8 0 <0.0011694
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FIGURE 2 .
￿
Clinical course of ar-
thritis induced in Lewis or Buffalo
rats . Asterisks indicate times at
which the right ankle mean joint
score for Lewis rats was signifi-
cantly higher than that for Buf-
falo rats (t test for independent
means, p < 0.01) . (A) The right
ankle joint of each of 14 Lewis
(0) and 14 Buffalo (O) rats was
injected intraarticularly with 10
Wg of S . typhimurium LT-2 LPS .
APS iv
￿
Left ankles received PBS (not
shown). On day 21, each strain
was injected with 25 tag of S . ty-
phimurium LT-2 LPS (seven rats)
B or Y . enterocolitica LPS (seven
rats) . No inflammation was noted
in left or right ankle joints after
this injection . (B) The right ankle
joint of each ofeight Lewis (0) or
Buffalo (O) rats was injected in-
traarticularly with 5 t<g of PG-
APS . Left ankles received PBS (A,
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with 25 lAg of S. typhimurium LT-
2 LPS.
with PG-APS had little or no evidence of acute inflammation, but did have some
residual mild chronic synovitis . This consisted of hyperplasia of the synovial
lining cells, fibrosis of the synovial stroma, diffuse and focal collections of
lymphocytes and macrophages, and limited pannus formation and marginal
erosion of the articular cartilage .
2 d after intravenous injection of LPS, a severe acute inflammatory exudate,
consisting primarily of polymorphonuclear leukocytes, fibrin, and some eryth-
rocytes, was seen in PG-APS-injected joints (Fig . 1, B-D). This was not seen in
PG-APS-injected joints of control rats given PBS instead of LPS.
By 8 d after injection of 10 jug of S . typhimurium LPS, the acute reaction in
PG-APS-injected joints had resolved . Mild chronic inflammation, similar to that
seen immediately before LPS injection, persisted and was still evident at 20 d.
In rats given a higher dose (100 gg) of E. coli LPS, the chronic inflammation in
PG-APS-injected joints 9 and 20 d after LPS injection was clearly more severe
than that at 2 d . In addition, a mild acute exudative reaction was still evident at
these times, suggesting an ongoing inflammatory process .
Acute synovitis following high-dose LPS injection was seen in contralateral
ankle joints initially injected with PBS . For clarity, this reaction is shown only in
Table II and Fig . 2B . This reaction was similar histologically and clinically to
that induced by LPS in naive rats (Table I, Fig. 1 A), except that it was usually
most severe 24 h after LPS injection . It was consistently of lower incidence,
severity, and duration than that seen in ankle joints previously exposed to PG-
APS.
Recurrence ofArthritis after Systemic Injection ofRe MutantLPS or Lipid A .
￿
The
ability of an intravenous injection of Re mutant LPS or lipid A to induce aSTIMPSON ET AL .
￿
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TABLE III
Recurrence ofArthritis Induced by Systemic Injection of Re Mutant LPS or Lipid A
* As forTable 11 .
$ Significance of the difference between this score and the next one listed (t test for independent
means) .
¢ Arthritis 24 h after endotoxin injection .
recurrence of arthritis in ajoint previously exposed to PG-APS was examined
(Table III) . In general, Re mutant LPSs were less active on a dry weight basis
than wild type LPS, and results were more variable . Nevertheless, they clearly
possessed some activity . Interestingly, the gonococcal LPS (Table 11) is similar to
Re mutant LPS in that it contains only lipid A and 2-keto-3-deoxyoctonic acid
(19), yet it was one of the most highly arthropathic LPSs tested . E. coli lipid A
was weakly active (Table 111) . Mixture of polymyxin B with Re mutant LPS
immediately before injection significantly reduced the incidence, severity, and
duration of recurrent arthritis (Table 111, Fig . 1, Eand F) .
Arthritis after Intraarticular Injection ofLPS .
￿
Intraarticular injection of 10 'Ug
ofS . typhimurium LT-2 LPS induced an acute course of arthritis that peaked in
severity -12 h after injection and then rapidly resolved to grossly undetectable
levels by day 6 (Fig . 2A) . This reaction was significantly more severe in Lewis
rats than in Buffalo rats . Injection of 25 /.tg of S. typhimurium LT-2 or Y .
enterocolitica LPS i .v . 3 wk after the intraarticular LPS injection did not induce
a recurrence of arthritis in either rat strain (Fig . 2A) . In another experiment,
100 jug of E. coli LPS injected intravenously 3 wk after intraarticular injection
of 10 lAg ofE . coli LPS did not induce gross or histologic evidence of arthritis in
LPS-injected or contralateral PBS-injectedjoints (data not shown) .
Injection of 300,ug of PG-APS intravenously, which will induce a recurrence
of arthritis in ajoint previously injected intraarticularly with PG-APS (7) did not
induce a recurrence of arthritis in joints injected intraarticularly 3 wk earlier
with 10 hg of S . typhimurium LT-2 LPS (data not shown) .
Exp . Endotoxin Rat strain Dose
Arthritis in PG-APS-injected (right)
joint48 h after endotoxin injection
Incidence* Meanjoint score
(t SEM)
t+8
1 S. typhimurium LT-2 LPS Sprague-Dawley 10 7/7 2.6 t 0.3 (P < 0.02)*
1 S. typhimurium G30/C21 10 6/8 1 .6 ± 0.3
Re mutant LPS
2 50 5/8 1 .3 t 0.2
3 Lewis 25 7/9 1.9t 0.4 (P < 0.005
3 S. typhimurium Re mutant 25 1/7 0.3 ± 0.2
LPS mixed with 250 tug
polymyxin B
4 E. coli Re mutant (strain Sprague-Dawley 50 4/8 1 .4t 0.3
515) lipidA
4 S . minnesota R595 Re mu- 50 8/8 2.3 t 0.2
tant LPS
1 50 4/10 1 .0± 0.2
1 10 4/101 0.7 t 0.21696
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TABLE IV
FRCS Analysis ofSplenocyte Subsetsfrom rnu/+ and rnu/rnu Rats
MRC MRC MRC
OX-1 OX-19 OX-8
rnu/+
￿
96 .4 10.2
￿
37 .8 ± 1 .0
￿
23 .6 ± 0.4
￿
23 .2 ± 0 .5
rnu/rnu
￿
93 .2 ± 0 .4
￿
1 .4 ± 0.9
￿
24 .6 ± 0.8
￿
6 .4 ± 0 .9
<0.001 <0.001 NS <0.001
Mean percent (± SEM)of splenocytes recognized by :*
W3/25
FIGURE 3 .
￿
Clinical course of arthritis induced
in rnu/+ (euthymic, 0) and rnu/rnu (athymic, p)
rats . The right ankle joint of each of five rnu/+
andfive rnu/rnu rats was injected intraarticularly
with 5 vg of PGAPS . Left ankles received PBS
(not shown) . On day 21, each rat was injected
intravenously with 25 Ag of S. typhimurium LT-2
LPS . Asterisks indicate times at which the mean
joint score for rnu/+ rats was significantly higher
than that for rnu/rnu rats (t test for independent
means, p < 0.025) .
MRC MRC MRC MRC
OX-7 OX-12 OX-6 OX-42
14.0±0 .9 37.0±0 .5 23.6±0 .9 18.6±2 .9
18.6±0 .7 45.6±1 .3 32.0±3 .0 35.0±3 .2#
<0.005 <0 .001 <0.025 <0.005
"' Splenocytes from five rnu/+ and five rnu/rnu rats from the experiment shown in Fig . 3 . These figures take into account controls for the
binding of FITC-conjugated goat anti-mouse IgG alone, for which the mean was usually<6% and never >8.8% .
This mean is based on four rats.
Significance of the difference in the mean for rnu/+ vs . rnu/rnu rats (t test for independent means) .
LPS-induced Recurrence ofArthritis in Athymic Rats .
￿
The role ofT lymphocytes
in LPS-induced recurrence of arthritis was examined by comparing the responses
of rnu/rnu (athymic) and rnu/+ (euthymic) rats (Fig . 3) . The intraarticular
injection of PG-APS induced acute arthritis in both strains, but arthritis in
rnu/rnu rats subsided more quickly than that in rnu/+ rats . A recurrence of
arthritis was induced in both rat strains by the intravenous injection of LPS 3
wk after intraarticular PG-APS injection . There was no difference in the course
of arthritis inmale (data not shown)andfemale rnu/+ rats . All rats were sacrificed
3 d after intravenous LPS injection for histological study of joints and FACS
analysis of splenocytes. A severe acute inflammatory exudate in the right ankle
joint of every rat was observed, and no significant differences between rnu/rnu
and rnu/+ rats were seen .
Splenocytes from the female rats were compared by FACS analysis to confirm
the T cell deficiency of rnu/rnu rats . As shown in Table IV, splenocytes from
rnu/rnu rats were severely deficient in cells recognized by the MRC OX-19
mAb, supporting the conclusion that T cells are not required for the LPS-
induced recurrence of arthritis in this model . Several other mAbs recognizing
other rat leukocyte antigens were also tested . Differences observed in the
splenocyte profiles include a decreased percentage of W3/25+ cells and an
increased percentage of MRC OX-6+ and MRC OX-12+ cells in rnu/rnu rats .
These differences have beennotedrecently by Vaessen, et al. (36) inacomparison
ofWAG rnu/rnu and rnu/+ rats of the same age (2 mo) as those used in the
present study . In addition, we noted an increased percentage ofMRC OX-42+
cells in rnu/rnu rats .
Effect of In Vivo Administration of Mutanolysin on LPS-induced Recurrence ofw
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FIGURE 4 .
￿
Clinical course ofarthritis
induced in Lewis rats showing the pro-
tective effect of mutanolysin treat-
ment . On day 0, the right ankle joint
of each of 19 Lewis rats was injected
intraarticularly with 5 jig of PG-APS .
Left ankle joints received PBS (not
shown). (A) Immediately afterPGAPS
injection, six rats were injected intra-
venously with 400 ug of mutanolysin
(O), and five rats received PBS (0) . (B)
On day 7, five rats were injected intra-
venously with 400 hg of mutanolysin
(O), and three rats received PBS (0) .
On day 19, all rats were injected intra-
venously with 25 ug of S . typhimurium
LT-2 LPS . Asterisks indicate times at
which the mean joint score for PBS-
treated rats was significantly higher
than that for mutanolysin-treated rats
(t test for independent means, p <
0.025) .
The intravenous injection of mutanolysin on day 0, immediately after
the intraarticular injection of PG-APS, resulted in an edematous reaction in the
anklejoints that was evident within 30 min (Fig . 4A). This reaction did not occur
in contralateral PBS-injected joints, nor in rats treated with PBS intravenously
immediately after intraarticular injections . By 4 h, arthritis in mutanolysin- and
PBS-treated rats was of the same severity, but after 24 h, arthritis in mutanolysin-
treated rats subsided more quickly than that in PBS-treated rats . Administration
of mutanolysin on day 7 had no effect on the rate at which the residual arthritis
subsided (Fig . 4B) . The intravenous injection of LPS on day 19 induced a
recurrence of arthritis in the PG-APS-injected joints of PBS-treated rats that was
ofhigher incidence, severity, and duration than that seen in mutanolysin-treated
rats (Fig . 4, A and B) . Some inflammation was also noted in contralateral PBS-
injected joints after the LPS injection, but no significant differences between
mutanolysin- and PBS-treated rats were seen in thesejoints .
This study demonstrates that the systemic injection ofa single sublethal dose
of LPS into rats induces a mild acute, transient arthritis in ^-50% of previously
uninjected rats . A similar transient acute arthritis in guinea pigs was described
in 1957 by Jones and Carter (16) . They used two or four daily injections of 0.5
mg i.v . ofS. paradysenteriae type Z pyridine-extracted (37) somatic antigen . Acute
transient polyarthritis after intraperitoneal injection of LPS into rats has also
been reported (17a). Of greater significance is the finding that systemic injection
of a relatively low dose (10 wg) of LPS inducesa recurrence ofarthritis in 100%
of joints that have been previously inflamed by the intraarticular injection of
PG-APS . The reaction is primarily a transient acute exudative process that is
superimposed on the mild residual chronic synovitis induced by the initial
intraarticular PG-APS injection . Thus, joint inflammation initiated by peptido-
glycan polymers can be sustained by distinct bacterial cell wall structures derived1698
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from indigenous as well as pathogenic bacteria. The timing of injections, the
time ofonset ofinflammation, and the histological features ofthis model indicate
that the recurrence of arthritis is not a Shwartzman reaction. In addition, a
recurrence of arthritis cannot be induced by the systemic injection of LPS after
an intraarticular injection of the homologous or a heterologous LPS.
LPS from avariety oforganismsinducesa recurrence ofarthritisin this model.
Three lines of evidence indicate that lipid A is the active moiety: (a) enterobac-
terial Re mutant LPS and an Re mutant-like gonococcal LPS are active; (b)
polymyxin B, which binds to lipid A(38) and blocks many biological activities of
LPS in vitroand in vivo (39, 40, reviewed in 41), blocks the arthropathic activity
ofRe mutant LPS; (c) E. coli lipid A is weakly active.
The different susceptibilities of inbred Lewis and Buffalo rats to LPS-induced
recurrence of arthritis correlate with past studies showing that Lewis rats are
more susceptible than Buffalo rats to arthritis induced by intraperitoneal (5, 42)
or intraarticular (15) injection of PG-APS. This differential susceptibility was
also noted after intraarticular LPS injection. Arthritis induced by intraperitoneal
injection of PG-APS is under polygenic control (5, 42). Because local PG-APS
injections were used in the present study, and because PG-APS can persist in
both Lewis and Buffalo rat tissues (43), differences in susceptibility to arthritis
in this model probably reflect genetic control of the inflammatory response to
PG-APS and LPS, and not to differences in the distribution ofthese polymers to
thejoint.
Our finding that inflammation induced in nude (athymic) rats by intraarticular
injection of PG-APS is less prolonged than that in euthymic rats is consistent
with the less severe chronic arthritis seen in nude rats after a systemic PG-APS
injection (44, 45). However, this did not influence the capacity ofLPS to induce
a recurrence ofarthritis, indicating that T lymphocytes are not required for the
transient acute reaction . A role for T lymphocytes in chronic synovitis after the
acute reaction cannot be excluded by the present studies, because all rats were
killed 3 d after LPS injection.
Phlogistic agents may exacerbate disease by localizing in previously injured
tissue (46). Past studies of reactivation of arthritis induced by intravenous
injection of homologous or heterologous'25I-labeled PG-PS revealed that more
PG-PS localizes to thejoint previously injured by intraarticular injection of PG-
APS than to the contralateral PBS-injected joint, presumably due in part to a
prolonged increase injoint vascular permeability (7). A synergistic effect of LPS
and muramyl dipeptide, the minimum essential peptidoglycan structure that
possesses many ofthe activities of peptidoglycan (47), has been demonstrated in
an in vivo model of antitumor activity (48) and in in vitro adjuvanticity assays
(49). More recently, Galelli and Chedid (50) reported a remarkable synergistic
effect of muramyl dipeptide and LPS on the induction of colony-stimulating
activity in mice.
We propose that the LPS-induced reactivation of arthritis described here
results from a complementary or synergistic interaction ofthe phlogistic activities
ofLPS and PG-APS. Such an interaction would likely involve the shared biologic
properties of these polymers (2) and may be related to structural similarities in
the lipid A and muramyl dipeptide moieties (51). LPS may play a particularlyimportant role in the link between reactive arthritis and gastroenteritis caused
by gram negative enteric pathogens such as Y . enterocolitica (52) and S . typhimu-
rium (53) ; as well as in aseptic arthritis associated with disseminated gonococcal
infection (54) .
Summary
Rat ankle joints injected intraarticularly with 5 ug of group A streptococcal
peptidoglycan-polysaccharide (PG-APS) developed an acute course of arthritis .
Recurrence of arthritis was induced in 100% of these joints by intravenous
injection of as little as 10 wg of Salmonella typhimurium lipopolysaccharide (LPS)
3 wk after intraarticular injection . This reaction was similar in athymic and
euthymic rats . Buffalo rats were less susceptible than Lewis or Sprague-Dawley
rats . Neisseria gonorrhoeae, Yersinia enterocolitica, and Escherichia coli LPS, and S.
typhimurium Re mutant LPS, were also active . Re mutant LPS activity was greatly
reduced by mixing with polymyxin B. E. coli lipidA was weakly active . An acute
synovitis of much less incidence, severity, and duration was seen in contralateral
joints injected initially with saline, and in ankle joints of naive, previously
uninjected rats after intravenous LPS injection . The intravenous injection of the
muramidase mutanolysin on day 0 or 7 after intraarticular PG-APS injection
prevented LPS-induced recurrence of arthritis . These studies suggest that the
phlogistic activities of lipid Aand peptidoglycan might interact in an inflamma-
tory disease process, and that LPS may play a role in recurrent episodes of
rheumatoid arthritis or reactive arthritis .
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